Implementation of the Medicare Prescription Drug Plan (PDP) and Medicare Advantage (MA) Plan Disenrollment Reasons Survey (CMS-10316)

ICR 202003-0938-016

OMB: 0938-1113

Federal Form Document

ICR Details
0938-1113 202003-0938-016
Active 201607-0938-007
HHS/CMS CM-CPC
Implementation of the Medicare Prescription Drug Plan (PDP) and Medicare Advantage (MA) Plan Disenrollment Reasons Survey (CMS-10316)
Revision of a currently approved collection   No
Regular
Approved with change 12/10/2020
Retrieve Notice of Action (NOA) 03/24/2020
Previous terms continue: When four years of data are available, CMS will evaluate the within-plan temporal variability in quality scores available to consumers and adjust the frequency of the data collection accordingly. If there is very little change in the quality scores across time, CMS will consider collecting the information less frequently and present a report to OMB.
  Inventory as of this Action Requested Previously Approved
12/31/2023 36 Months From Approved 12/31/2020
43,872 0 56,972
9,354 0 12,754
0 0 0

This information collection will survey disenrollees from Medicare Prescription Drug Plans (PDPs) and Medicare Advantage Prescription Drug Plans (MA-PDs). The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) provides a requirement to collect and report performance data for Part D prescription drug plans. Specifically, the MMA under Sec. 1860D-4 (Beneficiary Protections for Qualified Prescription Drug Coverage) requires CMS to conduct consumer satisfaction surveys regarding PDPs and MA-PDs - pursuant to section 1860D-4(d). This data collection complements the satisfaction data collected through the Medicare CAHPS Survey by providing dissatisfaction data in the form of reasons for disenrollment from PDPs and MA-PDs.

Statute at Large: 1 Stat. 1860 Name of Statute: null
  
None

Not associated with rulemaking

  84 FR 55966 10/18/2019
85 FR 16634 03/24/2020
Yes

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 43,872 56,972 0 0 -13,100 0
Annual Time Burden (Hours) 9,354 12,754 0 0 -3,400 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No
The proposed revisions reduce our estimated completion time per survey from 12 to 11 minutes for PDP survey responses, and from 14 to 13 minutes for MA responses. On an annualized basis, the estimate of respondent burden is also reduced from the estimate provided in our 2017 OMB application due to a reduction in response rates from ~40% (2017 OMB application assumption) to ~30% (based on observed response rates for the survey in years 2016 and 2017). Total burden has decreased from 12,754 to 9,354.

$1,717,335
Yes Part B of Supporting Statement
    No
    No
No
No
No
No
Stephan McKenzie 410 786-1943 stephan.mckenzie@cms.hhs.gov

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
03/24/2020


© 2024 OMB.report | Privacy Policy